Clinical Genetic Test
offered by
GTR Test Accession:
Help
GTR000508071.6
CAP
Last updated in GTR:
2024-06-28
View version history
GTR000508071.6,
last updated:
2024-06-28
GTR000508071.5,
last updated:
2023-07-03
GTR000508071.4,
last updated:
2022-07-12
GTR000508071.3,
last updated:
2021-07-13
GTR000508071.2,
last updated:
2019-07-26
GTR000508071.1,
registered in GTR:
2018-07-25
Last annual review date for the lab: 2024-06-28
LinkOut
At a Glance
Test purpose:
Help
Risk Assessment
Conditions (1):
Help
Congenital plasminogen activator inhibitor type 1 deficiency
Genes (1):
Help
SERPINE1 (7q22.1)
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: PCR
Target population: Help
Plasma plasminogen activator inhibitor, PAI-1 is a major inhibitor of …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Test short name:
Help
PAI 4G/5G
Specimen Source:
Help
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Health Care Provider
- Licensed Physician
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Test development:
Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required:
Help
Based on applicable state law
Test strategy:
Help
https://testdirectory.questdiagnostics.com/test/home
Pre-test genetic counseling required:
Help
No
Post-test genetic counseling required:
Help
No
Recommended fields not provided:
Lab contact for this test
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Targeted variant analysis
PCR
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Risk Assessment
Target population:
Help
Plasma plasminogen activator inhibitor, PAI-1 is a major inhibitor of fibrinolysis. The 4G variant (AF386492.2:g.837del) in the PAI-1 (Serpine 1) gene promoter region is associated with an increase in the level of PAI-1 in plasma. Increased levels of PAI-1 in plasma may increase the risk for arterial and venous thrombosis, …
View more
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS?
Help
not applicable
not applicable
Are family members with defined clinical status recruited to assess significance of VUS without charge?
Help
No. not applicable
No. not applicable
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Not provided.
Not provided.
Recommended fields not provided:
Clinical validity,
Clinical utility,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Analytical sensitivity and specificity = 99%
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
VUS:
Laboratory's policy on reporting novel variations
Help
not applicable
not applicable
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Clinical resources:
Molecular resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.